EUVIMEDEUVIMED entdecken
Open Access

Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use

Julia M Dennett, Gregg S Gonsalves

Health Affairs · 2023

DOI: 10.1377/hlthaff.2023.00146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Julia M Dennett und 1 weiteren Autor:innen. Beteiligte Einrichtung: Julia M. Dennett, Yale University, New Haven, Connecticut. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Drug Overdose, Communicable Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The initial marketing of the opioid analgesic OxyContin in 1996 increased fatal drug overdoses over the course of the opioid epidemic in the US. However, the long-term impacts of this marketing on complications of injection drug use, a key feature of the ongoing crisis, are undetermined. This study evaluated the effects of exposure to initial OxyContin marketing on the long-term trajectories of injection drug use-related outcomes in the US. We used a difference-in-differences analysis to compare outcomes in states with high versus low exposure to initial marketing before and after the 2010 reformulation of OxyContin, which facilitated the use of illicit drugs and the spread of infectious disease. Exposure to initial OxyContin marketing statistically significantly increased rates of fatal synthetic opioid-related overdoses; acute hepatitis A, B, and C viral infections; and infective endocarditis-related deaths. The greatest burden of adverse long-term outcomes has been in states that experienced the highest exposure to early OxyContin marketing. Our findings indicate that OxyContin marketing decisions from the mid-1990s increased viral and bacterial complications of injection drug use and illicit opioid-related overdose deaths twenty-five years later.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersDrug OverdoseCommunicable DiseasesHumansUnited StatesOxycodoneAnalgesics, OpioidMarketing

Stichwörter der Autor:innen

CANCERInfectious diseasesPain managementopioidspharmaceutical marketingsubstance use

Substanzen

OxycodoneAnalgesics, Opioid

Autor:innen und Institutionen

  • Julia M. Dennett, Yale University, New Haven, Connecticut.
  • Gregg S. Gonsalves (gregg.gonsalves@yale.edu), Yale University.

Förderung

  • NIDA NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Dennett, J. M., & Gonsalves, G. S. (2023). Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use. Health Affairs. https://doi.org/10.1377/hlthaff.2023.00146

Vancouver

Dennett JM, Gonsalves GS. Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use. Health Affairs. 2023. doi:10.1377/hlthaff.2023.00146

BibTeX
@article{Dennett2023,
  author = {Dennett, Julia M and Gonsalves, Gregg S},
  title = {Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use},
  journal = {Health Affairs},
  year = {2023},
  doi = {10.1377/hlthaff.2023.00146}
}
Kostenlos starten →